To the best of our knowledge, to date, there have been no studies evaluating LAL activity in patients with cryptogenic cirrhosis, which, in the majority of cases, is considered the result of long-lasting NASH [11,12]. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatohepatitis.